Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial

Douglass A Morrison1, Gulshan Sethi, Jerome Sacks

  • 1Tucson VA Medical Center and the University of Arizona, Tucson, Arizona 85723, USA. douglass.morrisson@med.va.gov

Insights

For patients with prior coronary artery bypass graft (CABG) surgery, percutaneous coronary intervention (PCI) showed comparable or better long-term survival than repeat CABG. PCI is a preferred option for many post-CABG individuals.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Repeat coronary artery bypass graft (CABG) surgery carries a higher mortality risk than primary CABG.
  • The Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) trial was the first randomized trial to compare CABG with percutaneous coronary intervention (PCI) in post-CABG patients.

Purpose of the Study:

  • To compare long-term survival rates between percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) in patients with previous CABG.
  • To evaluate the efficacy of PCI versus repeat CABG in high-risk patients with medically refractory myocardial ischemia.

Main Methods:

  • A cohort of 2,431 high-risk patients with medically refractory myocardial ischemia were screened over five years (1995-2000).
  • Survival outcomes were compared between CABG and PCI groups using Kaplan-Meier curves and log-rank tests across a randomized trial and two prospective registries (physician-directed and patient-choice).

Main Results:

  • In the randomized trial (142 post-CABG patients), 3-year survival was 73% for CABG vs. 76% for PCI (log-rank, NS).
  • In the physician-directed registry, 36-month survival was 71% for reoperation vs. 77% for PCI (log-rank, NS).
  • In the patient-choice registry, 36-month survival was significantly higher for PCI (86%) compared to reoperation (65%) (log-rank test, p = 0.01).

Conclusions:

  • Percutaneous coronary intervention (PCI) demonstrates comparable or superior long-term survival compared to repeat coronary artery bypass graft (CABG) in post-CABG patients.
  • PCI may be a preferable revascularization strategy for select post-CABG patients, particularly when patient choice is involved.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...